Albumin

protein

Albumin reduction in acute MI reflects systemic inflammation and oxidative stress, serving as a generic stress and hemodynamic marker.

Pathway placement

Cascade stepOff-pathway / systemic markers

Confidencemedium

RationaleSystemic acute-phase and oxidative stress marker; inverse predictor of vascular events.

Also acts inVascular inflammation

Druggability

Not assessed (no mapped human gene target).

Type I vs Type II discrimination

ScoresIndeterminate

R — rupture / Type-I

C — confounder / Type-II

A — assay feasibility

E — evidence strength

T1DI (composite)

Specificity differential (R−C)+25

Confounder panel (Type-II drivers)

1sepsis / systemic inflammationmag 2

2anemia / acute blood lossmag 1

3hypovolemia / dehydrationn/a

4tachyarrhythmian/a

5hypoxemia / respiratory failuremag 1

6hypertensive emergencyn/a

7high-demand / peri-operative stressmag 1

Coverage: 4/7 confounders with evidence

Tier: deep-scored (abstract-extracted) · 6 supporting references. See the discrimination table for all markers.

Validated clinical assay

Specimen

Serum or plasma; urine (microalbumin)

Collection tube

Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container

Method / principle

Dye-binding (BCG/BCP) or immunoturbidimetric (urine)

Reagent / substrate

Bromocresol green/purple; anti-albumin latex for urine

Platform

Automated analyzer

Turnaround · availability

Routine · Universal